Kukje Pharma Co., Ltd. (KRX: 002720)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,540.00
+20.00 (0.36%)
Nov 15, 2024, 3:30 PM KST
9.92%
Market Cap 117.90B
Revenue (ttm) 142.60B
Net Income (ttm) 363.44M
Shares Out 20.36M
EPS (ttm) 17.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 602,495
Open 5,450.00
Previous Close 5,520.00
Day's Range 5,340.00 - 5,600.00
52-Week Range 4,365.00 - 8,120.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Kukje Pharma

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAID... [Read more]

Sector Healthcare
Founded 1959
Employees 249
Stock Exchange Korea Stock Exchange
Ticker Symbol 002720
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.